Novel compounds

Details for Australian Patent Application No. 2004208824 (hide)

Owner Replidyne, Inc.

Inventors Hamprecht, Deiter Wolfgang; Jarvest, Richard Lewis

Agent Davies Collison Cave

Pub. Number AU-A-2004208824

PCT Pub. Number WO2004/069196

Priority 0302546.7 04.02.03 GB

Filing date 3 February 2004

Wipo publication date 19 August 2004

International Classifications

A61K 031/00

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/069196 Priority application(s): WO2004/069196

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004208825-Novel substituted 2,3-benzodiazepine derivatives

2004208821-Hydrogel compositions comprising nucleus pulposus tissue